The following pages link to Kirsten B. Holven (Q59830859):
Displaying 50 items.
- Comparison of bioavailability of krill oil versus fish oil and health effect (Q26781855) (← links)
- Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe). (Q33715779) (← links)
- Bioavailability of n-3 fatty acids from n-3-enriched foods and fish oil with different oxidative quality in healthy human subjects: a randomised single-meal cross-over study (Q33782239) (← links)
- Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics (Q33791924) (← links)
- Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis (Q34025504) (← links)
- Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects (Q34126000) (← links)
- Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children (Q34126112) (← links)
- Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects (Q34404742) (← links)
- Fish oil supplementation induces expression of genes related to cell cycle, endoplasmic reticulum stress and apoptosis in peripheral blood mononuclear cells: a transcriptomic approach (Q34678652) (← links)
- Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors (Q34680900) (← links)
- Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis (Q34983608) (← links)
- Fructose content of low calorie diets: effect on cardiometabolic risk factors in obese women with polycystic ovarian syndrome: a randomized controlled trial (Q35808764) (← links)
- Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children (Q36245157) (← links)
- Altered expression of genes involved in lipid metabolism in obese subjects with unfavourable phenotype (Q36947539) (← links)
- Effects of a healthy Nordic diet on gene expression changes in peripheral blood mononuclear cells in response to an oral glucose tolerance test in subjects with metabolic syndrome: a SYSDIET sub-study (Q37123153) (← links)
- The PBMC transcriptome profile after intake of oxidized versus high-quality fish oil: an explorative study in healthy subjects (Q37142034) (← links)
- Lack of Effects of a Single High-Fat Meal Enriched with Vegetable n-3 or a Combination of Vegetable and Marine n-3 Fatty Acids on Intestinal Peptide Release and Adipokines in Healthy Female Subjects (Q37218440) (← links)
- LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro (Q37242976) (← links)
- Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype (Q37297571) (← links)
- Gene expression is differentially regulated in skeletal muscle and circulating immune cells in response to an acute bout of high-load strength exercise (Q37679188) (← links)
- Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review (Q38218468) (← links)
- High-quality fish oil has a more favourable effect than oxidised fish oil on intermediate-density lipoprotein and LDL subclasses: a randomised controlled trial (Q38677100) (← links)
- Does intrauterine exposure to hypercholesterolemia adversely affect familial hypercholesterolemia phenotype? (Q38806017) (← links)
- Exchanging a few commercial, regularly consumed food items with improved fat quality reduces total cholesterol and LDL-cholesterol: a double-blind, randomised controlled trial (Q38808420) (← links)
- Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages (Q38832892) (← links)
- Interleukin-10 increases reverse cholesterol transport in macrophages through its bidirectional interaction with liver X receptor α. (Q38974452) (← links)
- Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia (Q39064202) (← links)
- LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors (Q39129455) (← links)
- Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis (Q39193513) (← links)
- Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013. (Q39236327) (← links)
- Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study (Q39455589) (← links)
- Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux (Q40301962) (← links)
- Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects (Q40352345) (← links)
- Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia (Q40634562) (← links)
- Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia (Q40991292) (← links)
- Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study (Q41992684) (← links)
- Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment (Q42228228) (← links)
- Does dietary fat affect inflammatory markers in overweight and obese individuals?-a review of randomized controlled trials from 2010 to 2016. (Q42370498) (← links)
- Effects of Exercise on Gene Expression of Inflammatory Markers in Human Peripheral Blood Cells: A Systematic Review (Q42541546) (← links)
- Marine n-3 Fatty Acids and Gene Expression in Peripheral Blood Mononuclear Cells (Q42918063) (← links)
- Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome (Q43237772) (← links)
- Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins (Q43291657) (← links)
- Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects (Q43601429) (← links)
- Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects (Q43957659) (← links)
- Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects (Q44356342) (← links)
- Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects (Q44482796) (← links)
- Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo Dependency of xanthomas/xanthelasms, smoking and gender (Q44604927) (← links)
- Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy (Q44914830) (← links)
- Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia (Q46224491) (← links)
- Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins (Q46247298) (← links)